Listing Thumbnail

    Global Veterinary Vaccine Market Size, Share 2025 - 2034

     Info
    Deployed on AWS
    Veterinary Vaccine Market Size, Trends and Insights By Vaccine (Livestock Vaccine [Porcine Vaccines, Poultry Vaccines, Bovine Vaccines, Other Livestock Vaccines], Companion Animal Vaccine [Canine Vaccines, Equine Vaccines, Feline Vaccines], By Technology (Inactivated Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, Toxoid Vaccines, Other Technologies), and By Region - Global Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2022 to 2030

    Overview

    Veterinary Vaccine Market

    Global Veterinary Vaccine Market: Overview

    According to Custom Market Insights (CMI), The Global Veterinary Vaccine Market  was estimated at nearly USD 9 billion in 2021. As per our study, the market is anticipated to reach a value of USD 15 billion by 2030 showing a CAGR of 5%.

    Scrutinizing the uncertainties of the COVID 19 pandemic, our research team is constantly tracking and assessing the impact of the pandemic on the Veterinary Vaccine Market. These comprehensive insights are included in our market search report as a key market contributor.

    The global Veterinary Vaccine Market research report offers an in-depth analysis of the global market size, which is further segmented into the regional and country level market size, and segmentation market growth. Also, it provides market share, sales analysis, competitive landscape, impact of domestic and global market participants, trade regulations, value chain optimization, recent key developments, strategic market growth analysis, opportunities analysis, product launches, and technological innovations.

    Over the projection period, it is anticipated that the market for veterinary vaccines will grow quickly. One of the most prevalent cattle diseases in the world is anthrax. Anthrax has been globally contained as a consequence of national initiatives, but it remains pervasive, according to a report released by the WHO. The absence of vaccination against the illness and the inexperience of recent generations of veterinarians in detecting and reporting the condition both contribute to the diseases prevalence. Various livestock illnesses are becoming more common along with this.

    In livestock production systems, animal diseases cause a wide range of problems, such as productivity losses, food insecurity, and revenue loss, all of which have a detrimental effect on human health. Thus, as a result of all these factors, veterinary animal vaccinations were introduced to the market.

    Get a Free Sample Report with All Related Graphs & Charts (with COVID 19 Impact Analysis): https://www.custommarketinsights.com/request-for-free-sample/?reportid=17915 

    Veterinary Vaccine Market: Growth Drivers

    The main reasons for the widespread acceptance of ruminants, particularly cattle vaccinations, around the world are the rising outbreaks of cattle disease and the continuously growing livestock population. Animals are an essential source of milk, food, meat, protein, and other industrial goods like wool and leather. The three most often used animal vaccinations for equine influenza, foot, and mouth disease, and rabies restrict the spread of infectious pathogens by simulating acquired immunity.

    The need for animal vaccines for the livestock population is rising as a result of growing concerns about food security and improved animal husbandry. Global livestock output has increased as a result of rising consumer demand for animal products. The demand for animal products is also rising as a result of a number of causes, including population expansion and variations in food choices brought on by changing lifestyles. These elements are contributing to the markets expansion. Additionally, the ongoing development of vaccinations and the spread of cattle diseases have contributed to the changing market dynamics.

    Report URL: https://www.custommarketinsights.com/report/veterinary-vaccine-market/ 

    Veterinary Vaccine Market: Regional Analysis

    The largest market share is held by North America. The Animal and Plant Health Inspection Services Center for Veterinary Biologics (CVB) oversees the regulation of veterinary vaccinations in the United States (APHIS). Animal health companies are granted establishment and product licenses by the CVB in order to produce and market veterinary biologics.

    The creation of non replicating recombinant antigen vaccines, live vector vaccines, nucleic acid mediated vaccines, as well as live gene deleted vaccinations are examples of developments in vaccine development in the United States. For instance, in January 2020, Zoetis, a renowned animal health business, added PoulvacProcerta HVT ND, a vectored recombinant vaccine for defense against Newcastle and Mareks disease viruses, to their chicken vaccine line up.

    Veterinary Vaccine Market: Recent developments

    • August 2022:The Department of Animal Husbandry, Chandigarh Administration (India), has decided to start immunization in veterinary facilities because of the ongoing lumpy skin disease outbreak among cattle in Punjab and Haryana as well as rare instances being reported from Chandigarh.
    • October 2020: Boehringer Ingelheim teamed up with Henke Sass Wolf to create a novel intramuscular needle free vaccine injection tool for pigs from the time of weaning till the conclusion of their nursery.

    Key Players:

    • MERCK
    • Boehringer Ingelheim International GmbH
    • Virbac
    • Zoetis Services LLC
    • Vetoquinol
    • Elanco
    • Ceva
    • Biovac
    • NEOGEN Corporation
    • ImmuCell Corporation

    Get a Free Sample Report with All Related Graphs & Charts (with COVID 19 Impact Analysis): https://www.custommarketinsights.com/request-for-free-sample/?reportid=17915 

    The global Veterinary Vaccine market is segmented as follows:

    By Vaccine

    • Livestock Vaccine
    • Porcine Vaccines
    • Poultry Vaccines
    • Bovine Vaccines
    • Other Livestock Vaccines
    • Companion Animal Vaccine
    • Canine Vaccines
    • Equine Vaccines
    • Feline Vaccines

    By Technology

    • Inactivated Vaccines
    • Live Attenuated Vaccines
    • Recombinant Vaccines
    • Toxoid Vaccines
    • Other Technologies

    On the basis of Geography

    North America

    • The U.S.
    • Canada
    • Mexico

    Europe

    • France
    • The UK
    • Spain
    • Germany
    • Italy
    • Rest of Europe

    Asia Pacific

    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia Pacific

    The Middle East & Africa

    • Saudi Arabia
    • UAE
    • Egypt
    • Kuwait
    • South Africa
    • Rest of the Middle East & Africa

    Latin America

    • Brazil
    • Argentina
    • Rest of Latin America

    Browse Other Custom Market Insights coverage of the Global TECHNOLOGY Industry

    Details

    Delivery method

    Deployed on AWS
    New

    Introducing multi-product solutions

    You can now purchase comprehensive solutions tailored to use cases and industries.

    Multi-product solutions

    Features and programs

    Financing for AWS Marketplace purchases

    AWS Marketplace now accepts line of credit payments through the PNC Vendor Finance program. This program is available to select AWS customers in the US, excluding NV, NC, ND, TN, & VT.
    Financing for AWS Marketplace purchases

    Pricing

    Global Veterinary Vaccine Market Size, Share 2025 - 2034

     Info
    This product is available free of charge. Free subscriptions have no end date and may be canceled any time.
    Additional AWS infrastructure costs may apply. Use the AWS Pricing Calculator  to estimate your infrastructure costs.

    Vendor refund policy

    No Refund Policy

    How can we make this page better?

    We'd like to hear your feedback and ideas on how to improve this page.
    We'd like to hear your feedback and ideas on how to improve this page.

    Legal

    Vendor terms and conditions

    Upon subscribing to this product, you must acknowledge and agree to the terms and conditions outlined in the vendor's End User License Agreement (EULA) .

    Content disclaimer

    Vendors are responsible for their product descriptions and other product content. AWS does not warrant that vendors' product descriptions or other product content are accurate, complete, reliable, current, or error-free.

    Usage information

     Info

    Delivery details

    AWS Data Exchange (ADX)

    AWS Data Exchange is a service that helps AWS easily share and manage data entitlements from other organizations at scale.

    Additional details

    Data sets (1)

     Info

    You will receive access to the following data sets.

    Data set name
    Type
    Historical revisions
    Future revisions
    Sensitive information
    Data dictionaries
    Data samples
    Global Veterinary Vaccine Market
    All historical revisions
    All future revisions
    Not included
    Not included

    Resources

    Vendor resources

    Similar products